Artesunate

Kathryn Dzintars, Pharm.D., BCPS
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
Artesunate is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • FDA approved for the treatment of severe malaria in adults and pediatric patients (May 2020)
    • Artesunate (as a single agent) is available for emergency use in the U.S. (contact CDC) for severe falciparum malaria.
    • Until drug supply is adequate in the U.S., the CDC remains the point of contact to obtain the drug.

NON-FDA APPROVED USES

  • Mild to moderate malaria falciparum.

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • FDA approved for the treatment of severe malaria in adults and pediatric patients (May 2020)
    • Artesunate (as a single agent) is available for emergency use in the U.S. (contact CDC) for severe falciparum malaria.
    • Until drug supply is adequate in the U.S., the CDC remains the point of contact to obtain the drug.

NON-FDA APPROVED USES

  • Mild to moderate malaria falciparum.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: July 3, 2020